Tap on and choose 'Add to Home Screen' to create a shortcut app

Tap on and choose 'Add to Home Screen/Install App' to create a shortcut app

Complications of Therapies for Neurocysticercosis in Children

This page was last updated on September 23rd, 2020

Surgical complications

  • No unique complications expected: The complications usually seen are common to other neurosurgical procedures, such as wound infection, CSF fistula, and postoperative hemorrhage. Ventricular bleeding can be seen after neuroendoscopy (5). Rupture of intraventricular or cisternal cysticercus during surgery is not associated with dissemination of the disease (2).

Medical complications

  • Worsening of symptoms: Antiparasitic drugs can induce an inflammatory response that includes headaches, dizziness, and a transient increase of seizures. Antiparasitic drugs should be introduced after a 3- to 5-day course of corticosteroids.
  • Seizures: Long-term antiepileptic therapy is required if the patient had preoperative convulsions. Residual lesions correlated significantly with seizure recurrence (60).
  • Secondary effects of antiparasitic drug therapy: Hepatotoxicity, leucopenia, and reversible alopecia have been reported (44).

Your donations keep us going

The ISPN Guide is free to use, but we rely on donations to fund our ongoing work and to maintain more than a thousand pages of information created to disseminate the most up-to-date knowledge in the field of paediatric neurosurgery.

By making a donation to The ISPN Guide you are also indirectly helping the many thousands of children around the world whose treatment depends on well-informed surgeons.

Please consider making a donation today.

Use the app

The ISPN Guide can be used as a standalone app, both on mobile devices and desktop computers. It’s quick and easy to use.

Fully featured

Free registration grants you full access to The Guide and host of featured designed to help further your own education.

Stay updated

The ISPN Guide continues to expand both in breadth and depth. Join our mailing list to stay up-to-date with our progress.